Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMPRSS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALDH6A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BAALC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDLIM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SH3BGR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
CACNB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZFX - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101928634 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RNF43 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UNC13B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
ABCB8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC13A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLITRK5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HIST1H3F - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PALLD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEMA3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPIL6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on